I am a physician-scientist and an Assistant Professor of Medicine in the Division of Blood and Marrow Transplantation and Cellular Therapy (BMT&CT). Clinically, I care for patients with high-risk lymphoma and other blood cancers. I am the principal investigator of clinical trials investigating novel chimeric antigen receptor (CAR) T-cell therapies for the treatment of relapsed and refractory leukemia and lymphoma. These trials, in part, provide the critical and precious patient samples that are the subject of my laboratory-based research efforts. My research group is dedicated to understanding the clinical outcomes of our patients who receive these immunotherapies with the goal of improving clinical response while minimizing toxicity.